9 results on '"Bogorad, Roman L"'
Search Results
2. RNAi-nanoparticulate manipulation of gene expression as a new functional genomics tool in the liver.
- Author
-
Yin, Hao, Bogorad, Roman L., Barnes, Carmen, Walsh, Stephen, Zhuang, Iris, Nonaka, Hidenori, Ruda, Vera, Kuchimanchi, Satya, Nechev, Lubomir, Akinc, Akin, Xue, Wen, Zerial, Marino, Langer, Robert, Anderson, Daniel G., and Koteliansky, Victor
- Subjects
- *
RNA interference , *GENE expression , *GENOMICS , *LIVER , *SMALL interfering RNA - Abstract
Background & Aims The Hippo pathway controls organ size through a negative regulation of the transcription co-activator Yap1. The overexpression of hyperactive mutant Yap1 or deletion of key components in the Hippo pathway leads to increased organ size in different species. Analysis of interactions of this pathway with other cellular signals corroborating organ size control is limited in part due to the difficulties associated with development of rodent models. Methods Here, we develop a new model of reversible induction of the liver size in mice using siRNA-nanoparticles targeting two kinases of the Hippo pathway, namely, mammalian Ste20 family kinases 1 and 2 (Mst1 and Mst2), and an upstream regulator, neurofibromatosis type II (Nf2). Results The triple siRNAs nanoparticle-induced hepatomegaly in mice phenocopies one observed with Mst1 −/− Mst2 −/− liver-specific depletion, as shown by extensive proliferation of hepatocytes and activation of Yap1. The simultaneous co-treatment with a fourth siRNA nanoparticle against Yap1 fully blocked the liver growth. Hippo pathway-induced liver enlargement is associated with p53 activation, evidenced by its accumulation in the nuclei and upregulation of its target genes. Moreover, injections of the triple siRNAs nanoparticle in p53 LSL/LSL mice shows that livers lacking p53 expression grow faster and exceed the size of livers in p53 wild-type animals, indicating a role of p53 in controlling Yap1-induced liver growth. Conclusion Our data show that siRNA-nanoparticulate manipulation of gene expression can provide the reversible control of organ size in adult animals, which presents a new avenue for the investigation of complex regulatory networks in liver. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
3. Control of hepatocyte proliferation and survival by Fgf receptors is essential for liver regeneration in mice.
- Author
-
Padrissa-Altés, Susagna, Bachofner, Marc, Bogorad, Roman L., Pohlmeier, Lea, Rossolini, Thomas, Böhm, Friederike, Liebisch, Gerhard, Hellerbrand, Claus, Koteliansky, Victor, Speicher, Tobias, and Werner, Sabine
- Subjects
LIVER cells ,CELL proliferation ,FIBROBLAST growth factor receptors ,LIVER regeneration ,LABORATORY mice ,SMALL interfering RNA - Abstract
Objective Fibroblast growth factors (Fgfs) are key orchestrators of development, and a role of Fgfs in tissue repair is emerging. Here we studied the consequences of inducible loss of Fgf receptor (Fgfr) 4, the major Fgf receptor (Fgfr) on hepatocytes, alone or in combination with Fgfr1 and Fgfr2, for liver regeneration after PH. Design We used siRNA delivered via nanoparticles combined with liver-specific gene knockout to study Fgfr function in liver regeneration. Liver or blood samples were analysed using histology, immunohistochemistry, real-time RT-PCR, western blotting and ELISA. Results siRNA-mediated knockdown of Fgfr4 severely affected liver regeneration due to impairment of hepatocyte proliferation combined with liver necrosis. Mechanistically, the proliferation defect resulted from inhibition of an Fgf15-Fgfr4-Stat3 signalling pathway, which is required for injury-induced expression of the Foxm1 transcription factor and subsequent cell cycle progression, while elevated levels of intrahepatic toxic bile acids were identified as the likely cause of the necrotic damage. Failure of liver mass restoration in Fgfr4 knockdown mice was prevented at least in part by compensatory hypertrophy of hepatocytes. Most importantly, our data revealed partially redundant functions of Fgf receptors in the liver, since knockdown of Fgfr4 in mice lacking Fgfr1 and Fgfr2 in hepatocytes caused liver failure after PH due to severe liver necrosis and a defect in regeneration. Conclusions These results demonstrate that Fgfr signalling in hepatocytes is essential for liver regeneration and suggest activation of Fgfr signalling as a promising approach for the improvement of the liver's regenerative capacity. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
4. Ionizable Amphiphilic Dendrimer-Based Nanomaterials with Alkyl-Chain-Substituted Amines for Tunable siRNA Delivery to the Liver Endothelium In Vivo.
- Author
-
Khan, Omar F., Zaia, Edmond W., Yin, Hao, Bogorad, Roman L., Pelet, Jeisa M., Webber, Matthew J., Zhuang, Iris, Dahlman, James E., Langer, Robert, and Anderson, Daniel G.
- Subjects
DENDRIMERS ,SMALL interfering RNA ,CELL populations ,NANOPARTICLES ,LIVER cells - Abstract
A library of dendrimers was synthesized and optimized for targeted small interfering RNA (siRNA) delivery to different cell subpopulations within the liver. Using a combinatorial approach, a library of these nanoparticle-forming materials was produced wherein the free amines on multigenerational poly(amido amine) and poly(propylenimine) dendrimers were substituted with alkyl chains of increasing length, and evaluated for their ability to deliver siRNA to liver cell subpopulations. Interestingly, two lead delivery materials could be formulated in a manner to alter their tissue tropism within the liver-with formulations from the same material capable of preferentially delivering siRNA to 1) endothelial cells, 2) endothelial cells and hepatocytes, or 3) endothelial cells, hepatocytes, and tumor cells in vivo. The ability to broaden or narrow the cellular destination of siRNA within the liver may provide a useful tool to address a range of liver diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
5. In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight.
- Author
-
Dahlman, James E., Barnes, Carmen, Khan, Omar F., Thiriot, Aude, Jhunjunwala, Siddharth, Shaw, Taylor E., Xing, Yiping, Sager, Hendrik B., Sahay, Gaurav, Speciner, Lauren, Bader, Andrew, Bogorad, Roman L., Yin, Hao, Racie, Tim, Dong, Yizhou, Jiang, Shan, Seedorf, Danielle, Dave, Apeksha, Singh Sandhu, Kamaljeet, and Webber, Matthew J.
- Subjects
SMALL interfering RNA ,ENDOTHELIAL cells ,NANOPARTICLES ,MOLECULAR weights ,GENE expression - Abstract
Dysfunctional endothelium contributes to more diseases than any other tissue in the body. Small interfering RNAs (siRNAs) can help in the study and treatment of endothelial cells in vivo by durably silencing multiple genes simultaneously, but efficient siRNA delivery has so far remained challenging. Here, we show that polymeric nanoparticles made of low-molecular-weight polyamines and lipids can deliver siRNA to endothelial cells with high efficiency, thereby facilitating the simultaneous silencing of multiple endothelial genes in vivo. Unlike lipid or lipid-like nanoparticles, this formulation does not significantly reduce gene expression in hepatocytes or immune cells even at the dosage necessary for endothelial gene silencing. These nanoparticles mediate the most durable non-liver silencing reported so far and facilitate the delivery of siRNAs that modify endothelial function in mouse models of vascular permeability, emphysema, primary tumour growth and metastasis. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
6. Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates.
- Author
-
Yizhou Dong, Love, Kevin T., Dorkin, J. Robert, Sirirungruang, Sasilada, Yunlong Zhang, Delai Chen, Bogorad, Roman L., Hao Yin, Yi Chen, Vegas, Arturo J., Alabi, Christopher A., Sahay, Gaurav, Olejnik, Karsten T., Weiheng Wang, Schroeder, Avi, Lytton-Jean, Abigail K. R., Siegwart, Daniel J., Akinc, Akin, Barnes, Carmen, and Barros, Scott A.
- Subjects
SMALL interfering RNA ,NANOPARTICLES ,GENETIC disorder treatment ,LIPOPROTEINS ,LABORATORY mice ,APOLIPOPROTEIN E ,ENDOTHELIAL cells ,THERAPEUTICS - Abstract
siRNA therapeutics have promise for the treatment of a wide range of genetic disorders. Motivated by lipoproteins, we report lipopeptide nanoparticles as potent and selective siRNA carriers with a wide therapeutic index. Lead material cKK-E12 showed potent silencing effects in mice (ED
50 ∼ 0.002 mg/kg), rats (ED50 < 0.01 mg/kg), and nonhuman primates (over 95% silencing at 0.3 mg/kg). Apolipoprotein E plays a significant role in the potency of cKK-E12 both in vitro and in vivo. cKK-E12 was highly selective toward liver parenchymal cell in vivo, with orders of magnitude lower doses needed to silence in hepatocytes compared with endothelial cells and immune cells in different organs. Toxicity studies showed that cKK-E12 was well tolerated in rats at a dose of 1 mg/kg (over 100-fold higher than the ED50 ). To our knowledge, this is the most efficacious and selective nonviral siRNA delivery system for gene silencing in hepatocytes reported to date. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
7. Treatment of erythropoietin deficiency in mice with systemically administered siRNA.
- Author
-
Querbes, William, Bogorad, Roman L., Moslehi, Javid, Wong, Jamie, Chan, Amy Y., Bulgakova, Elena, Kuchimanchi, Satya, Akinc, Akin, Fitzgerald, Kevin, Koteliansky, Victor, and Kaelin, William G.
- Subjects
- *
ERYTHROPOIETIN , *SMALL interfering RNA , *RECOMBINANT erythropoietin , *HEPCIDIN , *PROLINE hydroxylase , *KIDNEY failure - Abstract
Anemia linked to a relative deficiency of renal erythropoietin production is a significant cause of morbidity and medical expenditures in the developed world. Recombinant erythropoietin is expensive and has been linked to excess cardiovascular events. Moreover, some patients become refractory to erythropoietin because of increased production of factors such as hepcidin. During fetal life, the liver, rather than the kidney, is the major source of erythropoietin. In the present study, we show that it is feasible to reactivate hepatic erythropoietin production and suppress hepcidin levels using systemically delivered siRNAs targeting the EglN prolyl hydroxylases specifically in the liver, leading to improved RBC production in models of anemia caused by either renal insufficiency or chronic inflammation with enhanced hepcidin production. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
8. Large-Scale Quantitative Proteomics Identifies the Ubiquitin Ligase Nedd4-1 as an Essential Regulator of Liver Regeneration.
- Author
-
Bachofner, Marc, Speicher, Tobias, Bogorad, Roman L., Muzumdar, Sukalp, Derrer, Carina P., Hürlimann, Fabrizio, Böhm, Friederike, Nanni, Paolo, Kockmann, Tobias, Kachaylo, Ekaterina, Meyer, Michael, Padrissa-Altés, Susagna, Graf, Rolf, Anderson, Daniel G., Koteliansky, Victor, auf dem Keller, Ulrich, and Werner, Sabine
- Subjects
- *
LIVER regeneration , *ORCHESTRATORS , *PROTEASOMES , *HEPATECTOMY , *CELL proliferation , *SMALL interfering RNA - Abstract
Summary The liver is the only organ in mammals that fully regenerates even after major injury. To identify orchestrators of this regenerative response, we performed quantitative large-scale proteomics analysis of cytoplasmic and nuclear fractions from normal versus regenerating mouse liver. Proteins of the ubiquitin-proteasome pathway were rapidly upregulated after two-third hepatectomy, with the ubiquitin ligase Nedd4-1 being a top hit. In vivo knockdown of Nedd4-1 in hepatocytes through nanoparticle-mediated delivery of small interfering RNA caused severe liver damage and inhibition of cell proliferation after hepatectomy, resulting in liver failure. Mechanistically, we demonstrate that Nedd4-1 is required for efficient internalization of major growth factor receptors involved in liver regeneration and their downstream mitogenic signaling. These results highlight the power of large-scale proteomics to identify key players in liver regeneration and the importance of posttranslational regulation of growth factor signaling in this process. Finally, they identify an essential function of Nedd4-1 in tissue repair. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
9. In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight
- Author
-
Dganit Danino, Omar F. Khan, Klaus Charisse, Matthew J. Webber, Akin Akinc, Yizhou Dong, Tatiana Novobrantseva, Shan Jiang, Roman L. Bogorad, Vera M. Ruda, Matthias Nahrendorf, Taylor E. Shaw, Dayna K. Mudge, Rubin M. Tuder, Aude Thiriot, Andrew Bader, Daniel G. Anderson, Mark W. Kieran, Hendrik B. Sager, Tim Racie, Christopher G. Levins, Lauren Speciner, Partha Dutta, Ulrich H. von Andrian, Robert Langer, Mario F. Perez, Siddharth Jhunjunwala, Kevin Fitzgerald, Avi Schroeder, Kamaljeet Singh Sandhu, Dipak Panigrahy, James E. Dahlman, Ludmila Abezgauz, Lynelle P. Smith, Hao Yin, Danielle Seedorf, Abigail K. R. Lytton-Jean, Victor Koteliansky, Gaurav Sahay, Carmen M. Barnés, Brian T. Kalish, Yiping Xing, Apeksha Dave, Institute for Medical Engineering and Science, Harvard University--MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology. Department of Biology, Massachusetts Institute of Technology. Department of Chemical Engineering, Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science, Koch Institute for Integrative Cancer Research at MIT, Dahlman, James E., Khan, Omar F., Jhunjhunwala, Siddharth, Shaw, Taylor E., Xing, Yiping, Sahay, Gaurav, Bader, Andrew, Bogorad, Roman L., Yin, Hao, Dong, Yizhou, Jiang, Shan, Seedorf, Danielle, Dave, Apeksha, Sandhu, Kamaljeet Singh, Webber, Matthew, Ruda, Vera M., Lytton-Jean, Abigail K. R., Levins, Christopher G., Langer, Robert, and Anderson, Daniel Griffith
- Subjects
Small interfering RNA ,Endothelium ,Polymers ,Biomedical Engineering ,Bioengineering ,Vascular permeability ,Nanotechnology ,Article ,Cell Line ,Mice ,In vivo ,RNA interference ,Neoplasms ,medicine ,Animals ,Humans ,Gene silencing ,General Materials Science ,RNA, Small Interfering ,Electrical and Electronic Engineering ,Chemistry ,Endothelial Cells ,Condensed Matter Physics ,Atomic and Molecular Physics, and Optics ,Cell biology ,medicine.anatomical_structure ,Cell culture ,Drug delivery ,Nanoparticles ,RNA Interference - Abstract
Dysfunctional endothelium contributes to more diseases than any other tissue in the body. Small interfering RNAs (siRNAs) can help in the study and treatment of endothelial cells in vivo by durably silencing multiple genes simultaneously, but efficient siRNA delivery has so far remained challenging. Here, we show that polymeric nanoparticles made of low-molecular-weight polyamines and lipids can deliver siRNA to endothelial cells with high efficiency, thereby facilitating the simultaneous silencing of multiple endothelial genes in vivo. Unlike lipid or lipid-like nanoparticles, this formulation does not significantly reduce gene expression in hepatocytes or immune cells even at the dosage necessary for endothelial gene silencing. These nanoparticles mediate the most durable non-liver silencing reported so far and facilitate the delivery of siRNAs that modify endothelial function in mouse models of vascular permeability, emphysema, primary tumour growth and metastasis., American Society for Engineering Education. National Defense Science and Engineering Graduate Fellowship, National Science Foundation (U.S.), Massachusetts Institute of Technology. Presidential Fellowship
- Published
- 2014
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.